PHARMACYCLICS Trademark

Trademark Overview

On Tuesday, March 27, 2001, a trademark application was filed for PHARMACYCLICS with the United States Patent and Trademark Office. The USPTO has given the PHARMACYCLICS trademark a serial number of 76230944. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 2, 2012. This trademark is owned by Pharmacyclics, Inc. The PHARMACYCLICS trademark is filed in the Medical Instrument Products category with the following description:

Medical devices used for cancer and cardiovascular disease, namely, coronary diffusing fiber, peripheral diffusing fiber, radial diffusing fiber, and microlens diffusing fiber, for coronary artery disease, peripheral vascular disease, coronary artery restenosis, and nasopharynegeal carcinoma
pharmacyclics

General Information

Serial Number76230944
Word MarkPHARMACYCLICS
Filing DateTuesday, March 27, 2001
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 2, 2012
Registration Number2976635
Registration DateTuesday, July 26, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 18, 2002

Trademark Statements

Goods and ServicesMedical devices used for cancer and cardiovascular disease, namely, coronary diffusing fiber, peripheral diffusing fiber, radial diffusing fiber, and microlens diffusing fiber, for coronary artery disease, peripheral vascular disease, coronary artery restenosis, and nasopharynegeal carcinoma
Pseudo MarkPHARMACY CLINICS

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 2, 2012
Primary Code010
First Use Anywhere DateFriday, September 18, 1998
First Use In Commerce DateFriday, September 18, 1998

Trademark Owner History

Party NamePharmacyclics, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 940854521
Party NamePharmacyclics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 940854521
Party NamePharmacyclics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 940854521

Trademark Events

Event DateEvent Description
Friday, March 2, 2012CANCELLED SEC. 8 (6-YR)
Tuesday, July 26, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, May 17, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, May 13, 2005ASSIGNED TO LIE
Thursday, May 12, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 1, 2005STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 1, 2005USE AMENDMENT FILED
Thursday, February 10, 2005PAPER RECEIVED
Monday, September 27, 2004EXTENSION 4 GRANTED
Friday, September 10, 2004EXTENSION 4 FILED
Friday, September 10, 2004PAPER RECEIVED
Wednesday, July 21, 2004ASSIGNED TO EXAMINER
Friday, March 5, 2004EXTENSION 3 GRANTED
Friday, March 5, 2004EXTENSION 3 FILED
Friday, May 7, 2004CASE FILE IN TICRS
Monday, March 8, 2004PAPER RECEIVED
Tuesday, September 9, 2003EXTENSION 2 GRANTED
Tuesday, September 9, 2003EXTENSION 2 FILED
Monday, September 15, 2003PAPER RECEIVED
Wednesday, April 30, 2003EXTENSION 1 GRANTED
Wednesday, February 19, 2003EXTENSION 1 FILED
Wednesday, April 30, 2003DIVISIONAL PROCESSING COMPLETE
Wednesday, February 19, 2003DIVISIONAL REQUEST RECEIVED
Wednesday, February 19, 2003PAPER RECEIVED
Tuesday, September 10, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2002PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2002NOTICE OF PUBLICATION
Friday, March 29, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 1, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 15, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 30, 2001NON-FINAL ACTION MAILED
Thursday, July 12, 2001ASSIGNED TO EXAMINER
Wednesday, July 11, 2001ASSIGNED TO EXAMINER

Related Keywords

pharmacyclics fiber diffusing disease coronary artery peripheral vascular restenosis carcinoma nasopharynegeal